1. Quantifying Gains in Data Quality for Sampling Plans Used in Clinical Trial Monitoring

   • Dennis W. King
   • Melynda Hazelwood

   Clinical Trials 01 April 2003 Pages: 135 - 141

2. Taiwan’s Experience with the Assessment of the Acceptability of the Extrapolation of Foreign Clinical Data for Registration Purposes

   • Yeong-Liang Lin
   • Herng-Der Chern
   • Mong-Ling Chu

   Clinical Trials 01 April 2003 Pages: 143 - 145

3. The Use of Cyclic Redundancy Check (CRC-32) and Adler-32 Checksums for Source Code Verification

   • Allan Glaser

   Clinical Trials 01 April 2003 Pages: 147 - 154

4. Hepatotoxicity in the Review of Clinical Safety Data

   • Yeong-Liang Lin
   • Herng-Der Chern
   • Mong-Ling Chu

   Drug Regulation 01 April 2003 Pages: 155 - 158

5. 21 CFR Part 11: The Role of Predicate Regulations and Associated Internal Policies

   • Tammala D. Woodrum

   Drug Regulation 01 April 2003 Pages: 159 - 164

6. Dimension Change Profile Analysis: A Systematic Approach to Health-Related Quality of Life Instrument Selection in Novel Applications

   • Matthew M. Murawski

   Statistics 01 April 2003 Pages: 165 - 175

7. Career Development of Statisticians in the Pharmaceutical Industry

   • Charles L. Liss

   Statistics 01 April 2003 Pages: 177 - 183

8. Modeling the Probability-Cost-Profitability Architecture of Portfolio Management in the Pharmaceutical Industry

   • Andreas Zipfel

   R R&D D Strategy and Management 01 April 2003 Pages: 185 - 205

9. Project Management as a Discipline within Pharmaceutical Contract Research Organizations

   • Ellis Wilson Jr.
   • James McDonough
   • Jann Nielsen

   R R&D D Strategy and Management 01 April 2003 Pages: 207 - 213

10. Good Laboratory Notebook Practices

    • King C. Lee

    R R&D D Strategy and Management 01 April 2003 Pages: 215 - 219

11. Exploration of the Relationship between Health-Related Quality of Life and the Price of Pharmaceutical Products

    • Matthew M. Murawski
    • Marko A. Mychaskiw
    • Jeffrey Surdej

    Public Policy and Law 01 April 2003 Pages: 221 - 231

12. Fee-for-Service Drug Information Centers

    • Miriam A. Ansong
    • Mary Lynn Moody
    • Joan Stachnik

    Drug Information 01 April 2003 Pages: 233 - 239

13. A Same-Day Standard for Responding to Drug Information Requests by a Pharmaceutical Company

    • Charles F. Curran
    • Murali N. Sundar
    • Daryl R. Wesche

    Drug Information 01 April 2003 Pages: 241 - 249

14. 5th Middle East Regulatory Conference

    • Paul Dearden
    • Kerstin Ahrendt-Sölter
    • Elaine Whiting

    Proceedings 01 April 2003 Pages: 251 - 256